Shaila Ballal

Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

Klaus F. Rabe, Fernando J. Martinez, Gary T. Ferguson et al. · New England Journal of Medicine · 2020 · 691 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years

Désirée van der Heijde, David Salonen, Barbara N. Weissman et al. · Arthritis Research & Therapy · 2009 · 412 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial

Gary T. Ferguson, Klaus F. Rabe, Fernando J. Martínez et al. · The Lancet Respiratory Medicine · 2018 · 400 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study

Fernando J. Martínez, Klaus F. Rabe, Gary T. Ferguson et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 266 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Beneficial effects of adalimumab on biomarkers reflecting structural damage in patients with ankylosing spondylitis.

Walter P. Maksymowych, Proton Rahman, Kam Shojania et al. · PubMed · 2008 · 53 citations

Medicine, Immunology, Pharmacotherapy +16